Intermediate-Risk Papillary Thyroid Cancer: Not Everyone Needs Radioactive Iodine
{{output}}
Introduction: Intermediate-risk papillary thyroid carcinoma (PTC) accounts for 40%-60% of newly diagnosed PTC and comprises a heterogeneous group with variable recurrence risk. The benefit of postoperative radioactive iodine (RAI... ...
